Photo Credit: EvilKhan

The following is a summary of “Surgical outcomes of transurethral enucleation with bipolar energy for benign prostatic hyperplasia: single surgeon’s initial experience,” published in the February 2025 issue of BMC Urology by Kim et al. 

Researchers conducted a retrospective study on transurethral enucleation with bipolar energy (TUEB) for benign prostatic hyperplasia (BPH). They analyzed initial surgical outcomes from a single surgeon’s experience. 

They retrospectively analyzed clinical data from 387 patients who underwent TUEB from 04/2016 to 06/2021. They used a transurethral resection in a saline system with a spatula loop (one-lobe enucleation technique). Patients were stratified by surgery period (early vs. late) and evaluated perioperatively. 

The results showed that 387 patients were analyzed with a mean age of 72.4 years and a prostate volume of 73.1 cc. Procedure time (116.0 vs 116.8 min, P=0.863), enucleation time (49.2 vs 46.1 min, P=0.099), morcellation time (26.5 vs 23.6 min, P=0.162), and enucleated tissue weight (26.1 g vs 27.9 g, P=0.350) were similar. Enucleated tissue weight per unit time (0.52 vs 0.58 g/min, P=0.037), reoperation rates for bleeding (9.8% vs 2.5%, P=0.002), and TURP conversion (19.2% vs 1.5%, P<0.001) differed significantly. At 6 months, rates of de novo stress incontinence (P=0.188), urethral stricture (P=0.158), and bladder neck contracture (P=0.477) showed no significant differences. 

Investigators found TUEB to be a safe and effective treatment for BPH, improving subjective and objective symptoms. With experience, bleeding complications and TURP conversion rates significantly decreased. 

Source: bmcurol.biomedcentral.com/articles/10.1186/s12894-025-01706-w